INSIGHTS ON DRUG DEVELOPMENT

• Optimizing Lipid Formulations For Targeted RNA-LNP Applications

  Learn about the considerations and challenges of using ionizable lipids, including the 5 types of lipids used for RNA delivery.

• Optimizing Pediatric Product Development For Commercialization Success

  Ensuring medication adherence in pediatric patients presents challenges for pharmacotherapy. Explore various dosing solutions and learn how to streamline your pediatric development journey.

• Increasing Delivery System Flexibility Through Solvent-Based Processing

  Learn how a biodegradable polymer platform that is compatible with many substrates can enable several applications as a drug eluting carrier with a wide variety of APIs.

• Modified Release Formulations: Extending Drug Commercial Lifecycle

  A CDMO with expertise in modified-release dosage forms can provide valuable assistance in formulation development, processing considerations, analytical challenges, and regulatory requirements.

• Applying Automation To The Manufacture Of Drug Delivery Devices

  7/12/2023

  Automated manufacturing is a powerful but often misunderstood tool available to produce drug delivery and other pharmaceutical devices — whether established designs or innovative new ideas.

• Analysis Of Drug-Excipient Incompatibility In Discovery And Formulation Development

  3/7/2024

  We analyze drug-excipient incompatibility using a microcalorimeter system equipped with a multi-sample cell capable of simultaneously measuring highly sensitive heat flow data from up to three samples.

• Drug Discovery And Screening, A Digital Era For RNA-LNP Therapeutics

  11/21/2022

  Learn about the key stages of drug discovery and screening as well as how to overcome bottlenecks in screening mRNA-LNPs to rapidly develop genomic medicines.

• Deliver Product Quality, Enhance Productivity In CHO-K1, CHO-S Cells

  6/20/2022

  Early identification of a robust, commercially available, optimized platform medium and cell line–specific feed could be the keys to achieving strong productivity and delivering product to market more rapidly.

• A More Human-Relevant Model To Advance AAV-Based Gene Therapies

  3/8/2024

  Learn about a liver-chip that offers a more human-relevant way of testing viral vectors compared to conventional models and why it is a promising tool for advancing AAV gene therapy.